Abstract

BackgroundThere has been a remarkable growth in approved oral anticancer agents (OAA) in recent years. This situation involves the pharmacist as a key part of the interdisciplinary team ensuring the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents.
Jalpa A Doshi ... Pengxiang Li
Journal of Clinical Oncology | VOL. 36
Jalpa A Doshi, et. al.Jalpa A Doshi ... Pengxiang Li
20 Dec 2017
Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States.
Lauren E Wilson ... Charles D Scales
Journal of Clinical Oncology | VOL. 38
Lauren E Wilson, et. al.Lauren E Wilson ... Charles D Scales
10 Oct 2020
Impact of Initiating Oral Anticancer Agent Therapy for Chronic Myelogenous Leukemia Among Adults with Multiple Chronic Conditions
Justin Gatwood ... Joel Farley
Blood | VOL. 140
Justin Gatwood, et. al.Justin Gatwood ... Joel Farley
15 Nov 2022
Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada
Rick Abbott ... Maria Whelan
Journal of Oncology Pharmacy Practice | VOL. 20
Rick Abbott, et. al.Rick Abbott ... Maria Whelan
08 Oct 2013
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports
Lorene Lipszyc ... Samy Babai
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Lorene Lipszyc, et. al.Lorene Lipszyc ... Samy Babai
22 Jul 2024
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time
Patricia M L A Van Den Bemt ... Liset Van Dijk
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Patricia M L A Van Den Bemt, et. al.Patricia M L A Van Den Bemt ... Liset Van Dijk
17 Jul 2024
Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug–drug interactions
Alena Pilková ... Martin Matoulek
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Alena Pilková, et. al.Alena Pilková ... Martin Matoulek
17 Jul 2024
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management
Giulia Cancellieri ... Piera Polidori
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Giulia Cancellieri, et. al.Giulia Cancellieri ... Piera Polidori
15 Jul 2024
View more papers